An accelerated surface-mediated stress assay of antibody instability for developability studies

Marie R G Kopp1, Adriana-Michelle Wolf Pérez2,3, Marta Virginia Zucca1

  • 1Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, Swiss Federal Institute of Technology , Zurich, Switzerland.

Mabs
|September 21, 2020
PubMed
Summary

A new hydrophobic nanoparticle surface-stress assay effectively predicts monoclonal antibody (mAb) instability and aggregation, complementing existing developability screening methods for therapeutic product development.

Related Concept Videos